[1] 姚成云, 黄新恩, 黎超, 李艳, 许红霞, 沈洪兵. 在晚期非小细胞肺癌中XRCC1和XPD基因多态性的联合和铂类化疗的关系. 徐州医学院学报, 2010, 30(6): 391-395.[2] Hammond EC, Seidman H. Smoking and cancer in the United States. Prev Med, 1980, 9(2): 169-173.[3] Mattson ME, Pollack ES, Cullen JW. What are the odds that smoking will kill you? Am J Public Health, 1987, 77(4): 425-431.[4] Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin, 2009, 59(4): 225-249.[5] Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, Stacey SN, Bergthorsson JT, Thorlacius S, Gudmundsson J, Jonsson T, Jakobsdottir M, Saemunds-dottir J, Olafsdottir O, Gudmundsson LJ, Bjornsdottir G, Kristjansson K, Skuladottir H, Isaksson HJ, Gudbjartsson T, Jones GT, Mueller T, Gottsäter A, Flex A, Aben KKH, de Vegt F, Mulders PFA, Isla D, Vidal MJ, Asin L, Saez B, Murillo L, Blondal T, Kolbeinsson H, Stefansson JG, Hansdottir I, Runarsdottir V, Pola R, Lindblad B, van Rij AM, Dieplinger B, Haltmayer M, Mayordomo JI, Kieme-ney LA, Matthiasson SE, Oskarsson H, Tyrfingsson T, Gudbjartsson DF, Gulcher JR, Jonsson S, Thorsteinsdottir U, Kong A, Stefansson K. A variant associated with nico-tine dependence, lung cancer and peripheral arterial dis-ease. Nature, 2008, 452(7187): 638-642.[6] Zeiger JS, Haberstick BC, Schlaepfer I, Collins AC, Corley RP, Crowley TJ, Hewitt JK, Hopfer CJ, Lessem J, McQueen MB, Rhee SH, Ehringer MA. The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco. Hum Mol Genet, 2008, 17(5): 724-734.[7] Saccone NL, Saccone SF, Hinrichs AL, Stitzel JA, Duan W, Pergadia ML, Agrawal A, Breslau N, Grucza RA, Hatsu-kami D, Johnson EO, Madden PA, Swan GE, Wang JC, Goate AM, Rice JP, Bierut LJ. Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet, 2009, 150B(4): 453-466.[8] Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F, Sulem P, Rafnar T, Esko T, Walter S, Gieger C, Rawal R, Mangino M, Prokopenko I, Mägi R, Keskitalo K, Gudjonsdottir IH, Gretarsdottir S, Stefansson H, Thompson JR, Aulchenko YS. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet, 2010, 42(5): 448-453.[9] Hoft NR, Corley RP, McQueen MB, Schlaepfer IR, Huiz-inga D, Ehringer MA. Genetic association of the CHRNA6 and CHRNB3 genes with to-bacco dependence in a nationally representative sample. Neuropsychopharmacology, 2009, 34(3): 698-706.[10] Picciotto MR, Caldarone BJ, Brunzell DH, Zachariou V, Stevens TR, King SL. Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behav-ioral phenotypes and possible clinical implications. Pharmacol Ther, 2001, 92(2-3): 89-108.[11] Jarvis MJ. Why people smoke. BMJ, 2004, 328(7434): 277-279.[12] Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lis-sowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V. A susceptibility locus for lung can-cer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 2008, 452(7187): 633-637.[13] Minna JD. Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the patho-genesis of lung cancer. J Clin Invest, 2003, 111(1): 31-33.[14] Spindel ER. Is nicotine the estrogen of lung cancer? Am J Respir Crit Care Med, 2009, 179(12): 1081-1082.[15] Wong HPS, Yu L, Lam EKY, Tai EKK, Wu WKK, Cho CH. Nicotine promotes colon tumor growth and angiogenesis through β-adrenergic activation. Toxicol Sci, 2007, 97(2): 279-287.[16] Al-Wadei HAN, Plum |